Rifampin was glycosylated by a pathogenic species of Nocardia, i.e., N
ocardia brasiliensis. The structures of two glycosylated, compounds (R
IP-1 and RIP-2) isolated from the culture broth of the bacterium were
determined to be 3-formyl-23-(O-[beta-D-glucopyranosyl])rifamycin SV a
nd 23-(O-[beta-D-glucopyranosyl])rifampin, respectively. Both compound
s lacked antimicrobial activity against other gram-positive bacteria a
s well as the Nocardia species.